161 related articles for article (PubMed ID: 9007858)
21. Meningioma.
Marosi C; Hassler M; Roessler K; Reni M; Sant M; Mazza E; Vecht C
Crit Rev Oncol Hematol; 2008 Aug; 67(2):153-71. PubMed ID: 18342535
[TBL] [Abstract][Full Text] [Related]
22. Phase II evaluation of interferon-alpha-2a for progressive or recurrent craniopharyngiomas.
Jakacki RI; Cohen BH; Jamison C; Mathews VP; Arenson E; Longee DC; Hilden J; Cornelius A; Needle M; Heilman D; Boaz JC; Luerssen TG
J Neurosurg; 2000 Feb; 92(2):255-60. PubMed ID: 10659012
[TBL] [Abstract][Full Text] [Related]
23. Clinical and histological features of multiple meningiomas compared with solitary meningiomas.
Huang H; Buhl R; Hugo HH; Mehdorn HM
Neurol Res; 2005 Apr; 27(3):324-32. PubMed ID: 15845217
[TBL] [Abstract][Full Text] [Related]
24. Impact of timing of radiation therapy on outcomes in atypical meningioma: A clinical audit.
Pant S; Tonse R; Kannan S; Moiyadi A; Shetty P; Epari S; Sahay A; Sastri GJ; Jalali R; Gupta T
Pract Radiat Oncol; 2018; 8(5):e275-e284. PubMed ID: 29861352
[TBL] [Abstract][Full Text] [Related]
25. Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation.
Aghi MK; Carter BS; Cosgrove GR; Ojemann RG; Amin-Hanjani S; Martuza RL; Curry WT; Barker FG
Neurosurgery; 2009 Jan; 64(1):56-60; discussion 60. PubMed ID: 19145156
[TBL] [Abstract][Full Text] [Related]
26. Atypical and malignant meningiomas: a clinicopathological review.
Mahmood A; Caccamo DV; Tomecek FJ; Malik GM
Neurosurgery; 1993 Dec; 33(6):955-63. PubMed ID: 8134008
[TBL] [Abstract][Full Text] [Related]
27. Combined intraperitoneal interferon alpha-2b and mitoxantrone in refractory ovarian cancer.
Mäenpää J; Kivinen S; Räisänen I; Sipilä P; Väyrynen M; Gröhn P
Ann Chir Gynaecol Suppl; 1994; 208():25-7. PubMed ID: 8092765
[TBL] [Abstract][Full Text] [Related]
28. A randomized phase 2 trial of bevacizumab with or without daily low-dose interferon alfa-2b in metastatic malignant melanoma.
Varker KA; Biber JE; Kefauver C; Jensen R; Lehman A; Young D; Wu H; Lesinski GB; Kendra K; Chen HX; Walker MJ; Carson WE
Ann Surg Oncol; 2007 Aug; 14(8):2367-76. PubMed ID: 17534686
[TBL] [Abstract][Full Text] [Related]
29. [Problems in treatment for meningiomas].
Takahashi J; Hashimoto N
Nihon Rinsho; 2005 Sep; 63 Suppl 9():303-9. PubMed ID: 16201539
[No Abstract] [Full Text] [Related]
30. Expression of the JAK and STAT superfamilies in human meningiomas.
Magrassi L; De-Fraja C; Conti L; Butti G; Infuso L; Govoni S; Cattaneo E
J Neurosurg; 1999 Sep; 91(3):440-6. PubMed ID: 10470819
[TBL] [Abstract][Full Text] [Related]
31. Intraperitoneal recombinant interferon-alpha 2b for recurrent malignant ascites due to ovarian cancer.
Bezwoda WR; Seymour L; Dansey R
Cancer; 1989 Sep; 64(5):1029-33. PubMed ID: 2758381
[TBL] [Abstract][Full Text] [Related]
32. Recurrent meningioma: salvage therapy with long-acting somatostatin analogue.
Chamberlain MC; Glantz MJ; Fadul CE
Neurology; 2007 Sep; 69(10):969-73. PubMed ID: 17785665
[TBL] [Abstract][Full Text] [Related]
33. [Meningioma: management of the most common brain tumour].
Hundsberger T; Surbeck W; Hader C; Putora PM; Conen K; Roelcke U
Praxis (Bern 1994); 2016 Apr; 105(8):445-51. PubMed ID: 27078728
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment.
Engenhart-Cabillic R; Farhoud A; Sure U; Heinze S; Henzel M; Mennel HD; Bertalanffy H
Strahlenther Onkol; 2006 Nov; 182(11):641-6. PubMed ID: 17072521
[TBL] [Abstract][Full Text] [Related]
35. Brain invasion assessability in meningiomas is related to meningioma size and grade, and can be improved by extensive sampling of the surgically removed meningioma specimen.
Pizem J; Velnar T; Prestor B; Mlakar J; Popovic M
Clin Neuropathol; 2014; 33(5):354-63. PubMed ID: 25034703
[TBL] [Abstract][Full Text] [Related]
36. Meningioma treated with interferon-alpha, evaluated with [(11)C]-L-methionine positron emission tomography.
Muhr C; Gudjonsson O; Lilja A; Hartman M; Zhang ZJ; Långström B
Clin Cancer Res; 2001 Aug; 7(8):2269-76. PubMed ID: 11489801
[TBL] [Abstract][Full Text] [Related]
37. Intracranial Meningiomas: A 30-Year Experience and Literature Review.
Mehdorn HM
Adv Tech Stand Neurosurg; 2016; (43):139-84. PubMed ID: 26508409
[TBL] [Abstract][Full Text] [Related]
38. A prognostic cytogenetic scoring system to guide the adjuvant management of patients with atypical meningioma.
Aizer AA; Abedalthagafi M; Bi WL; Horvath MC; Arvold ND; Al-Mefty O; Lee EQ; Nayak L; Rinne ML; Norden AD; Reardon DA; Wen PY; Ligon KL; Ligon AH; Beroukhim R; Dunn IF; Santagata S; Alexander BM
Neuro Oncol; 2016 Feb; 18(2):269-74. PubMed ID: 26323607
[TBL] [Abstract][Full Text] [Related]
39. Meningiomas in children and adolescents.
Zwerdling T; Dothage J
J Pediatr Hematol Oncol; 2002; 24(3):199-204. PubMed ID: 11990306
[TBL] [Abstract][Full Text] [Related]
40. Scalp Metastases of Recurrent Meningiomas: Aggressive Behavior or Surgical Seeding?
Avecillas-Chasin JM; Saceda-Gutierrez J; Alonso-Lera P; Garcia-Pumarino R; Issa S; López E; Barcia JA
World Neurosurg; 2015 Jul; 84(1):121-31. PubMed ID: 25765926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
